What strategies will you adopt to bring success to Bio-XCell?

Mr Ramli: Bio-XCell has a three-phase development strategy that spans over six years. We must optimize value in each phase, in promoting the national biotechnology agenda and in enhancing the ecosystem at Bio-XCell. In phase I, we will focus on biomanufacturing and bioprocessing. Construction and development will support the needs of MNCs for manufacturing and related services.

In phase II, we will focus on R&D. We will emphasize on local industry participation to undertake research projects for future product pipeline. We also hope to develop local capabilities through technology transfer and technology licensing in this phase.

Phase III is where R&D projects from phase II would be scaled up for commercialization. The production of new products and technologies will open opportunities for collaboration with resident tenant manufacturers. This will complete the R&D and commercialization cycle, creating a sustainable biotechnology ecosystem at Bio-XCell. During this time, we hope to cultivate global brands in biotechnology, in line with phase III of the National Biotechnology Policy.

The micro strategies for each phase will be refined as we go along, in line with global and regional market trends in optimizing value creation for the local biotechnology sector and the economy.